HEATHER MORRIS: Open Payments
NPI 1174548457 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 87 payments from 14 companies in 2025. Trend: 2023 $757 · 2024 $1,116 · 2025 $1,703
Food & beverage: $1,669Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 23 | $388 |
| AstraZeneca Pharmaceuticals LP | 14 | $330 |
| Amgen Inc. | 20 | $275 |
| ARS Pharmaceuticals Operations, Inc. | 10 | $204 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| CSL Behring | 2 | $76 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Genentech USA, Inc. | 3 | $60 |
| Pharming Healthcare, Inc. | 2 | $50 |
| GENZYME CORPORATION | 1 | $38 |
Products named: TRELEGY ELLIPTA, TEZSPIRE, NEFFY, AIRSUPRA, FASENRA, NUCALA, DUPIXENT, Xolair.
Industry payments across TX — which companies pay providers there.
